VTR

— Fundamental Stock Analysis and Report Card

Real Estate : REIT - Healthcare Facilities

Located in Chicago, IL, US. As an S&P 500 company, Ventas operates strategically at the nexus of the dynamic healthcare and real estate industries. We stand as one of the world's foremost Real Estate Investment Trusts (REITs), utilizing financial capital to unlock property value. Our partnerships extend to leading care providers, developers, research and medical institutions, innovators, and healthcare organizations, all of whom benefit from the significant demographic trend of an aging population. For over two decades, Ventas has pursued a steadfast and effective strategy: maintaining a high-quality, diverse portfolio of assets and varied capital streams to skillfully navigate market fluctuations. A dedicated and experienced team collaborates with industry-leading partners to generate consistent, increasing cash flows and superior returns on a strong balance sheet, ultimately enriching Ventas's shareholders. As of September 30, 2020, Ventas either owned outright or managed through unconsolidated joint ventures approximately 1,200 properties.

Growth

Revenue, earnings and profitability.

Strong revenue growth and earnings can attract investors, driving the stock price up. Profitability indicates the company's efficiency and sustainability, which impacts investor confidence. Poor performance in these areas can lead to a decrease in stock price.

Revenue History

Earnings History

Margins

Gross Margin TTM
-4.26%
EBITDA Margin TTM
40.00%
Net Margin TTM
4.25%
Earnings Per Share TTM
0.55
Statements

Income & Cash Flow analysis.

An income statement shows what a company earned and spent over a period — revenue at the top, costs and expenses in between, and net income at the bottom. A cash flow statement tracks the actual cash moving in and out, across operations, investing, and financing. Read together, they show whether reported earnings are backed by real cash.

Ventas, Inc.
Select Period:
Q1 2026
Total ($)
Q1 2026
Margin (%)
Revenue
1.7b
+298.9m
+22.0%
Gross Income
655.4m
+83.0m
+14.5%
40%
-2.6pp
-6.1%
EBITDA
730.2m
+214.1m
+41.5%
44%
+6.1pp
+16.0%
Operating Income
191.6m
-6.1m
-3.1%
12%
-3.0pp
-20.6%
Net Income
55.9m
+9.0m
+19.3%
3%
-0.1pp
-2.2%
Earnings Per Share
0.12
+0.0
+9.1%
Operating Cash Flow
394.6m
+73.5m
+22.9%
24%
+0.2pp
+0.7%
Free Cash Flow
-576.9m
-839.1m
-320.0%
-35%
-54.1pp
-280.3%
Research & Development
n/a
n/a
n/a
n/a
n/a
n/a